These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus. Moberly SP; Mather KJ; Berwick ZC; Owen MK; Goodwill AG; Casalini ED; Hutchins GD; Green MA; Ng Y; Considine RV; Perry KM; Chisholm RL; Tune JD Basic Res Cardiol; 2013 Jul; 108(4):365. PubMed ID: 23764734 [TBL] [Abstract][Full Text] [Related]
5. Postconditioning with curaglutide, a novel GLP-1 analog, protects against heart ischemia-reperfusion injury in an isolated rat heart. Salling HK; Döhler KD; Engstrøm T; Treiman M Regul Pept; 2012 Oct; 178(1-3):51-5. PubMed ID: 22749991 [TBL] [Abstract][Full Text] [Related]
6. Exendin-4 inhibits structural remodeling and improves Ca Chen J; Wang D; Wang F; Shi S; Chen Y; Yang B; Tang Y; Huang C Peptides; 2017 Apr; 90():69-77. PubMed ID: 28242257 [TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor. Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966 [TBL] [Abstract][Full Text] [Related]
8. DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion. Ku HC; Chen WP; Su MJ Naunyn Schmiedebergs Arch Pharmacol; 2011 Aug; 384(2):197-207. PubMed ID: 21748358 [TBL] [Abstract][Full Text] [Related]
9. Antidiabetic Drug Alogliptin Protects the Heart Against Ischemia-reperfusion Injury Through GLP-1 Receptor-dependent and Receptor-independent Pathways Involving Nitric Oxide Production in Rabbits. Baba S; Iwasa M; Higashi K; Minatoguchi S; Yamada Y; Kanamori H; Kawasaki M; Nishigaki K; Minatoguchi S J Cardiovasc Pharmacol; 2017 Dec; 70(6):382-389. PubMed ID: 28817485 [TBL] [Abstract][Full Text] [Related]
10. PET of glucagonlike peptide receptor upregulation after myocardial ischemia or reperfusion injury. Gao H; Kiesewetter DO; Zhang X; Huang X; Guo N; Lang L; Hida N; Wang H; Wang H; Cao F; Niu G; Chen X J Nucl Med; 2012 Dec; 53(12):1960-8. PubMed ID: 23139087 [TBL] [Abstract][Full Text] [Related]
11. Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists. Evers A; Haack T; Lorenz M; Bossart M; Elvert R; Henkel B; Stengelin S; Kurz M; Glien M; Dudda A; Lorenz K; Kadereit D; Wagner M J Med Chem; 2017 May; 60(10):4293-4303. PubMed ID: 28448133 [TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 (7-36) but not (9-36) augments cardiac output during myocardial ischemia via a Frank-Starling mechanism. Goodwill AG; Tune JD; Noblet JN; Conteh AM; Sassoon D; Casalini ED; Mather KJ Basic Res Cardiol; 2014; 109(5):426. PubMed ID: 25005062 [TBL] [Abstract][Full Text] [Related]
13. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses. Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941 [TBL] [Abstract][Full Text] [Related]
14. Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats. Huisamen B; Genis A; Marais E; Lochner A Cardiovasc Drugs Ther; 2011 Feb; 25(1):13-20. PubMed ID: 21088878 [TBL] [Abstract][Full Text] [Related]
15. Antidiabetic drug voglibose is protective against ischemia-reperfusion injury through glucagon-like peptide 1 receptors and the phosphoinositide 3-kinase-Akt-endothelial nitric oxide synthase pathway in rabbits. Iwasa M; Kobayashi H; Yasuda S; Kawamura I; Sumi S; Yamada Y; Shiraki T; Yamaki T; Ushikoshi H; Aoyama T; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S J Cardiovasc Pharmacol; 2010 Jun; 55(6):625-34. PubMed ID: 20351564 [TBL] [Abstract][Full Text] [Related]
16. Obesity-related vascular dysfunction persists after weight loss and is associated with decreased vascular glucagon-like peptide receptor in female rats. Kiernan R; Persand D; Maddie N; Cai W; Carrillo-Sepulveda MA Am J Physiol Heart Circ Physiol; 2022 Aug; 323(2):H301-H311. PubMed ID: 35749717 [TBL] [Abstract][Full Text] [Related]
17. Exendin-4 ameliorates renal ischemia-reperfusion injury in the rat. Yang H; Li H; Wang Z; Shi Y; Jiang G; Zeng F J Surg Res; 2013 Dec; 185(2):825-32. PubMed ID: 23890403 [TBL] [Abstract][Full Text] [Related]
18. Time course of cardiometabolic alterations in a high fat high sucrose diet mice model and improvement after GLP-1 analog treatment using multimodal cardiovascular magnetic resonance. Abdesselam I; Pepino P; Troalen T; Macia M; Ancel P; Masi B; Fourny N; Gaborit B; Giannesini B; Kober F; Dutour A; Bernard M J Cardiovasc Magn Reson; 2015 Nov; 17():95. PubMed ID: 26546347 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors. Nauck MA; Meier JJ; Cavender MA; Abd El Aziz M; Drucker DJ Circulation; 2017 Aug; 136(9):849-870. PubMed ID: 28847797 [TBL] [Abstract][Full Text] [Related]
20. GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality. Anderberg RH; Richard JE; Hansson C; Nissbrandt H; Bergquist F; Skibicka KP Psychoneuroendocrinology; 2016 Mar; 65():54-66. PubMed ID: 26724568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]